Literature DB >> 12649068

New mutations in two Dutch patients with early infantile galactosialidosis.

J Groener1, P Maaswinkel-Mooy, V Smit, M van der Hoeven, J Bakker, Y Campos, A d'Azzo.   

Abstract

Galactosialidosis is an autosomal recessive lysosomal storage disease caused by a combined deficiency of lysosomal beta-galactosidase and neuraminidase as a result of a primary defect in the protective protein/cathepsin A (PPCA). We report the first 2 Dutch cases of early infantile galactosialidosis, both presenting with neonatal ascites. The defect was identified in urine, leukocytes, and fibroblasts. Residual activity was determined with a modified assay for cathepsin A and was <5% in leukocytes and <1% in fibroblasts. Histological examination of the placenta in case 1 showed extensive vacuolization in all cell types. Northern blot analysis of RNA isolated from the patients' cultured fibroblasts showed substantially decreased levels of the PPCA transcript, which nevertheless had the correct size of 2 kb. Mutation analysis of both mRNA and genomic DNA from the patients identified two novel mutations in the PPCA locus. Case 1 was a compound heterozygote, with a single missense mutation in one allele, which resulted in Gly57Ser amino acid substitution, and a single C insertion at nucleotide position 899 in the second allele, which gave rise to a frame shift and premature termination codon. Case 2 was homozygous for the same C899 insertion found in case 1. Copyright 2003 Elsevier Science (USA)

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12649068     DOI: 10.1016/s1096-7192(03)00005-2

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  4 in total

Review 1.  Lysosomal storage disorders in the newborn.

Authors:  Orna Staretz-Chacham; Tess C Lang; Mary E LaMarca; Donna Krasnewich; Ellen Sidransky
Journal:  Pediatrics       Date:  2009-04       Impact factor: 7.124

2.  A Turkish case of galactosialidosis with a new homozygous mutation in CTSA gene.

Authors:  Ayşe Kartal; Kürşad Aydın
Journal:  Metab Brain Dis       Date:  2017-05-30       Impact factor: 3.584

3.  Galactosialidosis: historic aspects and overview of investigated and emerging treatment options.

Authors:  Ida Annunziata; Alessandra d'Azzo
Journal:  Expert Opin Orphan Drugs       Date:  2016-12-14       Impact factor: 0.694

Review 4.  Galactosialidosis: review and analysis of CTSA gene mutations.

Authors:  Anna Caciotti; Serena Catarzi; Rodolfo Tonin; Licia Lugli; Carmen Rodriguez Perez; Helen Michelakakis; Irene Mavridou; Maria Alice Donati; Renzo Guerrini; Alessandra d'Azzo; Amelia Morrone
Journal:  Orphanet J Rare Dis       Date:  2013-08-02       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.